Revenue | ₹14,141.08Cr |
Net Profits | ₹2,903.38Cr |
Net Profit Margins | 20.53% |
Sun Pharmaceuticals Industries Ltd’s revenue jumped 11.96% since last year same period to ₹14,141.08Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 3.63% jump in its revenue since last 3-months.
Sun Pharmaceuticals Industries Ltd’s net profit jumped 15.04% since last year same period to ₹2,903.38Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated -4.5% fall in its net profits since last 3-months.
Sun Pharmaceuticals Industries Ltd’s net profit margin jumped 2.76% since last year same period to 20.53% in the Q3 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated -7.85% fall in its net profit margins since last 3-months.
The revenue for Sun Pharmaceuticals Industries Ltd in the Q3 results 2024 was ₹14,141.08Cr.
The net profit for Sun Pharmaceuticals Industries Ltd in the Q3 results 2024 was ₹2,903.38Cr.
The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q3 results 2024 was 20.53%.
The revenue for Sun Pharmaceuticals Industries Ltd in the Q3 results 2023 was ₹12,630.90Cr.
The net profit for Sun Pharmaceuticals Industries Ltd in the Q3 results 2023 was ₹2,523.75Cr.
The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q3 results 2023 was 19.98%.